Abstract
Background Referred to as the “silent killer,” elevated blood pressure often goes unnoticed due to the absence of apparent symptoms, resulting in cumulative harm over time. While various health conditions contribute to hypertension, they collectively account for a minority of cases. Chronic stress has been identified as a significant factor in increased blood pressure, and the heterogeneous nature of stress responses makes it challenging to identify specific deleterious behaviors through traditional clinical interviews.
Objective We aim to leverage machine learning algorithms for real-time predictions of stress-induced blood pressure spikes using consumer wearable devices such as FitBit, providing actionable insights to both patients and clinicians to improve diagnostics and enable proactive health monitoring.
Methods The study proposes the development of machine learning algorithms to analyze biosignals obtained from these wearable devices, aiming to make real-time predictions about blood pressure spikes.
Results We have developed the core study application, named CardioMate. CardioMate will be used to remind participants to initiate blood pressure readings using an Omron HeartGuide wearable monitor. The project described is supported as a pilot project from the Robert C. Perry Fund of the Hawai’i Community Foundation. This protocol was approved by the University of Hawai’i Institutional Review Board (IRB) under protocol #2023-00130.
Conclusions Personalized machine learning when applied to biosignals is a promising approach to providing the mobile sensing backend support for real-time digital health interventions for chronic stress and its corresponding symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The project described is supported as a pilot project from the Robert C. Perry Fund of the Hawaii Community Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This protocol was approved by the University of Hawaii Institutional Review Board (IRB) under protocol #2023-00130.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
kargaran{at}hawaii.edu
pyw{at}hawaii.edu
Data Availability
All data produced in the present study are available upon reasonable request to the authors
